Laure Frésard is a computational genomics leader with over 15 years of experience translating molecular biology into clinical impact, currently heading Dry Lab Research at GeneDx. She has pioneered machine learning-driven variant interpretation platforms that have informed diagnoses for millions of patients, and led integration of in silico splicing predictors and RNA assays into clinical frameworks. Her work spans academia and industry—from developing eigenMT and rare-disease transcriptome methods at Stanford to building scalable evidence-generation teams at Labcorp and Invitae—bridging cutting-edge methods and deployable clinical solutions. Known for combining deep statistical genetics expertise with pragmatic product delivery, she excels at turning complex genomic signals (including noncoding and splicing variation) into actionable clinical evidence.
11 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Molecular genomics, Doctor of Philosophy (Ph.D.) Molecular genomics at Université Paul Sabatier Toulouse III
Master of Science (M.S.) Biology applied to animal production and health (BAPSA), Master of Science (M.S.) Biology applied to animal production and health (BAPSA) at Université de Rennes I
Contributions:2 PRs, 42 pushes, 3 branches in 3 days
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Laure Frésard - Senior Director Of Translational Genetics